Association of the IGF-I promoter P1 polymorphism with risk of cervical cancer

European Journal of Gynaecological Oncology

Volumn 32, Issue 4, 2011, Pages 393-398

  Pacholska Bogalska, J ^a   Jozefiak A ^b   Nowak, W ^a   Kedzia W ^b   Kwasniewska A ^c   Gozdzicka Jozefiak A ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cervical cancer; Human papilloma viruses; IGF I promoter P1 polymorphism

Indexed keywords

SOMATOMEDIN C;

ADULT; ARTICLE; CANCER RISK; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFE CYCLE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRECANCER; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

ADULT; AGED; DNA, VIRAL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 80052778050     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. zur Hausen H.: "Papillomaviruses and cancer: from basic studies to clinical application". Nat. Rev. Cancer, 2002, 2, 342.
2. Bosch F.X., Lorincz A, Munoz N, Meijer CJ, Shah KV.: "The causal relation between human papillomavirus and cervical cancer". J. Clin. Pathol., 2002, 55, 244.
3. Doorbar J.: "The papilloma life cycle". J. Clin. Virol., 2005, 32, 7.
4. Chan J.M., Stampfer M.J., Giovannucci E., Gann P.H., Ma J., Wilkinson P. et al.: "Plasma insulin-like growth factor 1 and prostate cancer risk: a prospective study". Science, 1998, 279, 563.
5. Giovannucci E., Pollak M.N., Platz E., Willen W.C., Stampfer M.J., Majeed N. et al.: "A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women". Cancer Epidemiol. Biomarkers Prev., 2000, 9, 345.
6. Hankinson S.E., Willett W.C., Colditz G.A., Hunter D.J., Michaud D.S. Deroo B. et al.: "Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer". Lancet, 1998, 351, 1393.
7. Ma J., Pollak M.N., Giovannucci E., Chan J.M., Tao Y., Hennekens C.H., Stampfer M.J.: "Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3". J. Natl. Cancer Inst., 1999, 91, 620.
8. Petridou E., Dessypris N., Spanos E., Mantzoros C., Skalkidou A., Kalmanti M. et al.: "Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia". Int. J. Cancer, 1999, 80, 494.
9. Yu H., Spitz M.R., Mistry J., Gu J., Hong W.K., Wu X.: "Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control study". J. Natl. Cancer Inst., 1999, 9, 151.
10. Cohen P.: "Overview of the IGF-I system." Horm. Res., 2006, 65, 3.
11. Moschos S.J., Mantzoros C.S.: "The role of the IGF system in cancer: from basic to clinical studies and clinical applications". Oncology, 2002, 65, 317.
12. Sandhu S.M., Dunger D.B., Giovannucci E.L.: "Insulin, insulin like growth factor (IGF-I), IGF binding proteins, their biological interactions, and colorectal cancer". J. Natl. Cancer Inst., 2002, 94, 972.
13. Smith J.P., Spurrel E.L., Coakley J., Hinds C.J., Ross R.J., Kraimer A.R., Chew S.L.: "An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by splicing factor". Endocrinology, 2002, 143, 146.
14. Mittanck D.W., Kim S.W., Rotwein P.: "Essential promoter elements are located within the 5′ untranslated region of human insulin-like growth factor-I exon I". Mol. Cell Endocrinol., 1997, 126, 153.
15. Yu H., Li B.D., Smith M., Shi R., Berkel H.J, Kato I.: "Polymorphic CA repeats in the IGF-I gene and breast cancer". Breast Cancer Res. Treat., 2001, 70, 117.
16. Rotwein P., Pollock K.M., Watson M., Milbrandt J.D.: "Insulin-like growth factor gene expression during rat embryogenic development". Endocrinology, 1987, 12, 2141.
17. Józefiak A., Pacholska-Bogalska J., Myga-Nowak M., Kȩdzia W., Kwaśniewska A, Łuczak M. et al.: "Serum and tissue levels of insulin-like growth factor-I in women with dysplasia and HPV-positive cervical cancer". Mol Med. Report., 2008, 1, 231.
18. Obrepalska-Steplowska A., Kedzia A., Trojan J., Goździcka- Józefiak A.: "Analysis of coding region and promoter sequences of coding and promoter sequences of the IGF-I gene in children with growth disorders presenting with normal and normal level of growth hormone". J. Pediatr. Endocrinol. Metab., 2003, 16, 1267.
19. Steenbergen R.D., De Wilde J., Wilting S.A., Brink A., Snijders P., Meijer C.: "HPV mediated transformation of the anogenital tract". J. Clin. Virol., 2005, 32S, S25.
20. Wynes M.W., Riches D.W.: "Transcription of macrophage IGF-I exon is positively regulated by the 5′ untranslated region and negatively regulated by the 5′ flanking region". Am. J. Physiol. Lung Cell Mol. Physiol., 2005, 288, 1089.
21. Pash J.M., Delany A.M., Adamo M.L., Roberts C.T., LeRoith D., Canalis E.: "Regulation of insulin-like growth factor I transcription by prostaglandin E2 in osteoblast cells". Endocrinology, 1995, 135, 33.
22. Wong H.L., Delellis K., Probst-Hensch N., Koh W.P., Van Den Berg D., Lee H.P. et al.: "A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese". Cancer Epidemiol. Biomarkers Prev., 2005, 14, 144.
23. Rietveld J., Janssen J.A., Van Rossum E.E., Houwing-Duistermaat J.J., Pivadeneira E., Hofman A. et al.: "A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height". Clin. Endocrinol., 2004, 61, 195.
24. Voorhoeve P.G., Van Rossum E.F., te Velde S.J., Koper J.W., Kemper H.C., Lamberts S.W., Delemarre-van de Waal H.A.: "Association between an IGF-I gene polymorphism and body fatness: differences between generations". Eur. J. Endocrinol., 2006, 154, 379.
25. Rosen C.J., Kurland E.S., Vereault D., Adler R.A., Rackoff P., Craig W.Y. et al.: "Association between serum insulin like growth factor I (IGF-I) and a simple sequence repeat in IGF-I gene: implication for genetic studies of bone mineral density". J. Clin. Endocrinol. Met., 1998, 83, 2286.
26. Suzuki H., Li Y., Dong X., Hassan M.M., Abbruzzese J.L., Li D.: "Effect of IGF-I gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer". Cancer Epidemiol. Biomarkers Prev., 2008, 17, 3467.
27. Vaessen N., Heutink P., Janssen J.A., Witteman J.C., Testers L., Hofman A. et al.: "A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infraction". Diabetes, 2001, 50, 637.
28. Vaessen N., Janssen J.A., Heutink P., Hofman A., Lamberts S.W., Oostra B.A. et al.: "Association between genetic variation in the gene for insulin like growth factor I and low birth weight". Lancet, 2002, 359, 1036.
29. Samson S.L., Wong N.C.: "Role of Sp1 in insulin regulation of gene expression". J. Mol. Endocrinol., 2002, 29, 265.
30. Wierstra I.: "Sp1: Emerging roles - beyond constitutive activation of TATA-less housekeeping genes". Biochem. Biophys. Res. Commun., 2008, 372, 1.
31. Grinstein E., Jundt F., Weinert I., Wernet P., Royer H.D.: "SP1 as G1 cell cycle phase specific transcription factor in epithelial cells". Oncogene, 2002, 21, 1485.
32. Zhu J.L., Kaytor E.N., Pao C.I., Meng X.P., Phillips S.: "Involvement of Sp1 in the transcriptional regulation in the rat insulin-growth factor-1 gene". Mol. Cell. Endocrinol., 2000, 164, 205.
33. Tapias A., Ciudad C.J., Roninson I.B., Noe V.: "Regulation of SP1 by cell cycle related proteins". Cell Cycle, 2008, 7, 2856.
34. Steller M.A., Delgado C.H., Bartels C.J., Woodworth C.D., Zou Z.: "Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells". Cancer Res., 1996, 56, 1761.
35. Koutsodontis C., Vasilaki E., Chou W.C., Papakosta P., Kardassis D.: "Physical and functional interactions between members of the tumor suppressor p53 and Sp families of transcription factors: importance for the regulation of gene involved in cell-cycle arrest and apoptosis". Biochem. J., 2005, 389, 443.